Partnering with pharmaceutical companies is a critical pathway for emerging biotechs looking to advance their assets and accelerate development. In this seminar, experienced industry speakers will share practical insights from real-world collaborations—offering a behind-the-scenes perspective on how to capture big pharma’s attention, navigate the evaluation and due-diligence process, and select the most appropriate collaboration model. The speakers will also explore deal structures, effective partnership management, the realities of co-development, and provide candid guidance on what to do if an asset is returned.
Key Topics:
- How to capture big pharma’s attention
- Navigating the evaluation and due-diligence process
- Selecting the right collaboration and deal models
- Effective partnership and alliance management
- Co-development insights and handling asset returns
Organized by SwedenBIO Business Strategy Working Group
